GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) Stock
NEW YORK STOCK EXCHANGE, INC. · GSK
50.22
Fundamentals
Market cap
$100.62B
Price / Earnings ratio
15.9x
Price / Sales ratio
2.3x
Price / Book ratio
4.3x
Return on assets
0.1%
Ex-Dividend date
14 Aug 2026
Last payment date
N/A
Dividend amount
$0.43
Dividend yield
3.5%
Debt / Equity ratio
N/A
Latest news
About GSK plc American Depositary Shares (Each representing two Ordinary Shares)
GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.
SectorHealthcare
IndustryDrug Manufacturers - General
Employees66,841
CEOMr. Luke Victor Miels
IPO DateJul 9, 1986
HeadquartersLondon, United Kingdom
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Ms. Julie Belita Brown A.C.A. | CFO & Executive Director | 1962 |
| Ms. Emma Natasha Walmsley | Executive Officer | 1969 |
| Dr. Jesse L. Goodman M.D., M.P.H. | Scientific & Medical Expert | 1951 |
| Mr. Luke Victor Miels | CEO & Director | 1974 |
| Ms. Shobie Ramakrishnan | Chief Digital & Technology Officer | 1971 |
| Mr. Tony Wood | Chief Scientific Officer and Head of R&D | — |
| Mr. Constantin Fest | Senior VP & Head of Investor Relations | 1977 |
| Mr. James Ford | Senior VP and Group General Counsel of Legal & Compliance | — |
| Mr. David Simon Redfern BSc (Hons), CA | President of Corporate Development | 1966 |
| Ms. Roanne Parry | Chief People Officer | 1974 |
Fundamentals
Valuation
Market cap$100.62B
Price-to-sales ratio2.31
Price-to-book value4.35
Price-earnings ratio15.90
Return on Equity36.00%
Return on Sales0.23%
Return on Assets0.10%
PEG ratio6.00
Earnings Per Share
Earnings Per Share$3.20
Income Statement
Average volume2,765,021
EBITDA$12.76B
1 year high (52w)$61.70
1 year low (52w)$39.29
Dividend
Ex dividend date14 Aug 2026
Dividend amount$0.43
Dividend yield3.55%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



